Polycystic ovary syndrome
clinical and laboratory evaluation
Keywords:
Polycystic Ovary syndrome, Oligomenorrhea, Secondary amenorrheaAbstract
OBJECTIVE: To evaluate clinically, and with laboratory, tests, women with polycystic ovary syndrome (PCO). PATIENTS: One hundred and twelve women with PCO were studied. METHODS: The following data was recorded: Current age; age at menarche; menstrual irregularity, occurrence of similar cases in the family; fertility, obstetric history; body mass index (BMI); and presence of hirsutism. Serum measurements of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin, free testosterone, and dehydroepiandrosterone sulfate were taken. RESULTS: All patients presented either oligomenorrhea (31 percent), periods of secondary amenorrhea (9 percent), or both alterations (60 percent). The majority of the patients were infertile (75.6 percent). The LH/FSH ratio was higher than 2:1 in 55 percent of the patients and higher than 3:1 in 26.2 percent. The ultrasonographic aspect of the ovaries was considered to be normal in 31 percent. CONCLUSION: The main clinical feature of the PCO is the irregularity of menses since menarche, and that the laboratory tests would be important to exclude other disorders such as hyperprolactinemia or hyperandrogenemia caused by late-onset congenital adrenal hyperplasia.
Downloads
References
Stein IF, Leventhal M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-91.
Hutchinson-Williams KA, DeCherney AH Pathogenesis and treatment of ovary disease. Int J Fertil 1987;32:421-30.
Speroff L, Glass RH, Kase NG. In: Clinical Gynecology and Infertility 4th ed..Baltimore: Williams & Wilkins. I989;213-31
Yen SSC. Anovulação crônica causada por distúrbios endócrinos periféricos. In: Yen SSC, Jaffe B, eds. Endocrinologia reprodutiva: fisiologia fisiopatologia e tratamento clínico. São Paulo: Roca, 1990:423-69.
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-8.
Bangham DR, Berryman I, Burger H, et al. An international collaborative study of 69/104 a reference preparation of pituitary FSH and LH. J Clin Endocrinol Metab 1973;36:647-60.
Vieira JGH, Russo EMK, Lengyel AM, Maciel RMB. Desenvolvimento de um radioimunoensaio heterólogo para a dosagem de prolactina humana no soro. Arq Bras Endocrinol Metab 1981;25:107-12.
Jung-Hoffmann C, Taubert D, Kuhl H. Direct radioimmunoassay of free testosterone in the evaluation of androgenetic manifestation in women. Gynecol Endocrinol 1987;1:83-92.
Vieira JGH, Furlanetto RP, Russo EMK, Noguti KO, Chacra AR. Radioimunoensaio do sulfato de dehidroepiandrosterona: metodologia e padronização de valores normais. Arq Bras Endocrinol Metab 1980;24:79-93.
Lobo RA. The role of the adrenal in polycystic ovary syndrome. Semin Reprod Endocrinol 1984:2:251-262.
Futterweit W, Mechanick JI. Polycystic ovarian disease: Etiology diagnosis and treatment. Compr Ther 1988; 14:12-20.
Goldzieher JW, Green JA. The polycystic ovary: I. clinical and histologic features. J Clin Endocrinol Metab 1962;22:325-38.
Adams J, Poison DW, Franks S. The prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986; 293:355-8.
McKnight E. The prevalence of "hirsutism" in young women. Lancet 1964;1:410-3.
Corenblum B, Taylor PJ. The hyperprolactinemic polycystic ovary syndrome may not be a distinct entity. Fertil Steril 1982;38:549-52.
Seppälä M, Hirvonen E. Raised serum prolactin levels associated with hirsutism and amenorrhoea. Br Med J 1975;4:144-5.
Del Pozo ES, Falashi P. Prolactin and cyclicity in polycystic ovary syndrome: The role of estrogens and the dopaminergic system. Prog Reprod Biol 1980;6:252-9.
Futterweit W. Hyperprolactinemia and polycystic ovarian disease. In: Futterweit W. Polycystic ovarian disease. New York: Springer-Verlag, 1984; 97-111.
Yen SSC. The polycystic ovary syndrome. Clin Endocrinol 1980;12:177-208.
De Sá MFS, De Medeiros SF, De Moura MD, Ferrari RA. Ausência de correlação entre o grau de hirsutismo nos níveis de androgênios circulantes. J Bras Ginec 1988;98:45-8.
Hámori M, Urbancse J, Szendei G, Német J. The role of ultrasonography in treating polycystic ovary syndrome. Act Chir Hung 1988;29:27-34.
